| 发明名称 |
EXTENDING SURVIVAL OF CANCER PATIENTS WITH ELEVATED LEVELS OF EGF OR TGF-ALPHA |
| 摘要 |
The present application describes extending survival in a cancer patient, where the patient is producing an elevated level of EGF or TGF-alpha, by tr eating the patient with a HER dimerization inhibitor, such as pertuzumab.</S DOAB> |
| 申请公布号 |
CA2654584(A1) |
申请公布日期 |
2007.12.21 |
| 申请号 |
CA20072654584 |
申请日期 |
2007.05.31 |
| 申请人 |
GENENTECH, INC.;F.HOFFMANN-LA ROCHE AG |
发明人 |
STRAUSS, ANDREAS;AMLER, LUKAS C.;MOECKS, JOACHIM;RABBEE, NUSRAT |
| 分类号 |
A61K39/395;C07K16/32 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
